Topic Overview
What is attention deficit hyperactivity disorder (ADHD)?
Attention deficit hyperactivity disorder (ADHD) is a condition in which
a person has trouble paying attention and focusing on tasks, tends to act
without thinking, and has trouble sitting still. It may begin in early
childhood and can continue into adulthood. Without treatment, ADHD can cause
problems at home, school, work, and with relationships. In the past, ADHD was
called attention deficit disorder (ADD).
What causes ADHD?
The exact cause is not clear,
but ADHD tends to run in families.
What are the symptoms?
The three types of ADHD
symptoms include:
-
Trouble paying attention. People with ADHD are easily distracted and have a hard time
focusing on any one task.
-
Trouble sitting still for even a short time. This is called hyperactivity. Children with ADHD may
squirm, fidget, or run around at the wrong times. Teens and adults often feel
restless and fidgety and are not able to enjoy reading or other quiet
activities.
-
Acting before thinking. People
with ADHD may talk too loud, laugh too loud, or become angrier than the
situation calls for. Children may not be able to wait for their turn or to
share. This makes it hard for them to play with other children. Teens and
adults seem to "leap before they look." They may make quick decisions that have
a long-term impact on their lives. They may spend too much money or change jobs
often.
How is ADHD diagnosed?
ADHD is often diagnosed
when a child is between 6 and 12 years old. Teachers may notice symptoms in
children who are in this age group.
First, the child will have a
physical exam to make sure that he or she does not have other problems such as
learning disabilities,
depression, or anxiety disorder. The doctor will use
guidelines from the American Psychiatric Association to diagnose ADHD. The
doctor may also look at written reports about the child’s behavior. Parents,
teachers, and others who have regular contact with the child prepare these
reports.
How is it treated?
There is no cure for ADHD, but
treatment may help control the symptoms. Treatment may include medicines and
behavior therapy. Parents and other adults need to closely watch children after
they begin to take medicines for ADHD. The medicines may cause side effects
such as loss of appetite, headaches or stomachaches, tics or twitches, and
problems sleeping. Side effects usually get better after a few weeks. If they
don't, the doctor can lower the dose.
Therapy focuses on making
changes in the environment to improve the child’s behavior. Often, counseling
and extra support at home and at school help children succeed at school and
feel better about themselves.
How does ADHD affect adults?
Many adults don't
realize that they have ADHD until their children are diagnosed. Then they begin
to notice their own symptoms. Adults with ADHD may find it hard to focus,
organize, and finish tasks. They often forget things. But they also often are
very creative and curious. They love to ask questions and keep learning. Some
adults with ADHD learn to manage their lives and find careers that let them use
those strengths.
But many adults have trouble at home and work. As
a group, adults with ADHD have higher divorce rates. They also are more likely
to smoke and have more substance abuse problems than adults without ADHD. Fewer
adults with ADHD enter college, and fewer graduate. Treatment with medicine,
counseling, and behavior therapy can help adults with ADHD.
|
Frequently Asked Questions
|
|
Learning about ADHD:
|
|
|
Being diagnosed:
|
|
|
Getting treatment:
|
|
|
Ongoing concerns:
|
|
|
Living with ADHD:
|
|
National Institute of Mental Health (2003).
Attention Deficit Hyperactivity Disorder (NIH Publication No. 03-3572).
Available online: http://www.nimh.nih.gov/publicat/adhd.cfm.
Shaw P, et al. (2007). Attention-deficit/hyperactivity
disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences, 104(49):
19649–19654.
American Academy of Child and Adolescent Psychiatry
(2007). Practice parameter for the assessment and treatment of children and
adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7): 894–921.
Lamberg L (2003). ADHD often undiagnosed in adults:
Appropriate treatment may benefit work, family, social life. JAMA, 290(12): 1565–1567.
American Psychiatric Association (2000).
Attention-deficit and disruptive behavior disorders. In Diagnostic and Statistical Manual of Mental Disorders, 4th
ed., text rev., pp. 85–103. Washington, DC: American Psychiatric
Association.
Jensen PS, et al. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Developmental and Behavioral Pediatrics, 22(1): 60–73.
Schweitzer JB ,et al. (2001).
Attention-deficit/hyperactivity disorder. Medical Clinics of North America, 85(3): 757–777.
Pharmacology and young children: How safe is
methylphenidate in preschoolers? (2002). Brown University Psychopharmacology Update, 13(9): 2–3.
MTA Cooperative Group (2004). National Institute of
Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in
effectiveness and growth after the end of treatment. Pediatrics, 113(4): 762–769.
Jensen PS, et al. (2007). 3-year follow-up of the NIMH
MTA Study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8): 989–1002.
MTA Cooperative Group (1999). Moderators and
mediators of treatment response for children with
attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12): 1088–1096.
Jensen PS, et al. (2001). ADHD comorbidity findings
from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2): 147–158.
Wilens TE, et al. (2003). Does stimulant therapy of
attention-deficit/hyperactivity disorder beget later substance abuse: A
meta-analytic review of the literature. Pediatrics,
111(1): 179–185.
Weiss M, Murray C (2003). Assessment and management of
attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal, 168(6): 715–722.
U.S. Food and Drug Administration (2005). FDA issues
public health advisory on Strattera (atomoxetine) for attention deficit
disorder. FDA News P05-65. Available online:
http://www.fda.gov/bbs/topics/NEWS/2005/NEW01237.html.
Brue AW, Oakland TD (2002). Alternative treatments for
attention-deficit/hyperactivity disorder: Does evidence support their use?
Alternative Therapies, 8(1): 68–74.